Pembrolizumab vs Tirzepatide

## Pembrolizumab vs Tirzepatide: Overview

This comparison examines the pharmacological differences between **Pembrolizumab** and **Tirzepatide**.

## Mechanism of Action

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

**Tirzepatide**: Dual GIP and GLP-1 receptor agonist.

## Pharmacokinetics

**Half-life**: Pembrolizumab — 26 days; Tirzepatide — 5 days.

## Chemical Properties

**Type**: Pembrolizumab — Antibody; Tirzepatide — Protein.